Showing results (61-70 of 431) with videos related to

Sort By:
Pageof 44
Journal of Thoracic Disease|May 1, 2018
Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisitedJun Sato, Hidehito Horinouchi, Yasushi Goto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2011
Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasisSeiji Niho, Kaoru Kubota, Kiyotaka Yoh, et al.
Japanese Journal of Clinical Oncology|May 29, 2010
Randomized phase 2 dose-finding study of weekly administration of darbepoetin alpha in anemic patients with lung or ovarian cancer receiving multicycle platinum-containing chemotherapyYukito Ichinose, Takashi Seto, Yutaka Nishiwaki, et al.
Molecular and Clinical Oncology|January 27, 2017
Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term follow-up resultsEmi Kubo, Noboru Yamamoto, Hiroshi Nokihara, et al.
Cancer Science|April 12, 2020
CD20+ tumor-infiltrating immune cells and CD204+ M2 macrophages are associated with prognosis in thymic carcinomaJun Sato, Shigehisa Kitano, Noriko Motoi, et al.
Internal Medicine (Tokyo, Japan)|February 18, 2011
Development of Cushing's syndrome during effective chemotherapy for small cell lung cancerKoichi Suyama, Yoichi Naito, Kiyotaka Yoh, et al.
Japanese Journal of Clinical Oncology|April 7, 2004
Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancerSeiji Niho, Yuichiro Ohe, Koichi Goto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patientsYasushi Goto, Ikuo Sekine, Kazuhiko Yamada, et al.
Japanese Journal of Clinical Oncology|October 22, 2014
A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201)Junko Eba, Tsuneo Shimokawa, Kenichi Nakamura, et al.
Cancer Science|February 11, 2012
Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factorHidehito Horinouchi, Ikuo Sekine, Minako Sumi, et al.
Pageof 44